Related Experiment Videos
p53 expression and proliferative activity predict survival in non-invasive thymomas
1Department of Biomedical Sciences and Human Oncology, University of Turin, Italy.
International Journal of Cancer
|June 21, 1996
Summary
p53 protein expression and argyrophilic nucleolar organizer region (AgNOR) counts can predict prognosis in non-invasive thymomas. These markers offer valuable prognostic insights when other features are insufficient.
Area of Science:
- Oncology
- Pathology
- Molecular Biology
Background:
- Non-invasive thymomas are tumors of the thymus.
- Prognostic markers for non-invasive thymomas are needed.
- p53 protein and proliferative activity are potential biomarkers.
Purpose of the Study:
- To evaluate p53 immunohistochemistry, DNA flow cytometry, and AgNOR counts in non-invasive thymomas.
- To correlate these findings with clinicopathologic features and patient survival.
- To assess the prognostic value of p53 and AgNORs in non-invasive thymomas.
Main Methods:
- p53 immunohistochemistry performed on 46 non-invasive thymoma samples.
- DNA flow cytometry and AgNOR analysis were conducted.
- Correlation with clinicopathologic features and survival data.
Main Results:
- p53 immunopositivity found in 21/46 cases, correlating with AgNOR counts but not clinicopathologic features or DNA content.
- p53-positive cases had significantly lower 10-year survival (71%) compared to p53-negative cases (100%).
- High AgNOR counts were associated with lower survival rates (77%) compared to low AgNOR counts (93%).
Conclusions:
- p53 staining and AgNOR evaluation are valuable prognostic tools for non-invasive thymomas.
- These markers provide prognostic information when traditional features are insufficient.
- High p53 expression suggests early involvement of abnormal p53 in thymoma development.